Falang Database driver not enabled

TRiCares raises a Series B of €22m

TRiCares SAS, a portfolio company of CapDecisif Management pioneer in the field of minimally invasive treatment of tricuspid regurgitation, announces the successful completion of a €22 Million ($25.4 Million) Series B financing round.

Proceeds from the financing will be used to advance product development, to conduct clinical trials and to gain CE registration in Europe.

The financing round was led by incoming investors Wellington Partners, Germany, Andera Partners, France, and BioMed Partners, Switzerland and the existing French syndicate of CM-CIC Innovation, CapDecisif Management and GO Capital.

Website: http://www.tricares.com